MAPT and Alzheimer disease: 18F-florbetaben binding in vivo correlated strongly with neuritic plaques detected by Bielschowsky-silver staining and 6E10 immunostaining in AD brain [14], and showed no binding to alpha-synuclein or tau pathologies [23].